Market Research Reports and Industry Reports

Level Transmitter Market by Type (Capacitance, Radar, Ultrasonic, Differential Pressure, Magnetostrictive), by Industry (Oil & Gas, Chemical, Food & Beverage, Water & Wastewater, Power, Metal & Mining), and Region - Global Forecast to 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region. 
Major factors contributing to the growth of the digital therapeutics market include increasing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. Government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus for the growth of this market. For instance, in 2010, the U.S. Congress authorized the Centers for Disease Control and Prevention (CDC) to create the Diabetes Prevention Recognition Program (DPRP) and recognize programs that meet evidence-based standards provided by DPRP. This includes programs such as the “Prevent” program offered by Omada Health Inc. (U.S.) implemented for the prevention of diabetes. Additionally, the Affordable Care Act (2010) authorized a series of diabetes prevention programs under the National Diabetes Prevention Program (NDPP). One example of such a program is three digital diabetes prevention programs, provided by Canary Health (U.S.), Noom Health (U.S.), and Omada Health (U.S.), which received recognition in 2015. Such government initiatives are likely to provide an impetus for market growth. Relatively untapped markets in developing regions of Asia-Pacific and unexplored therapeutic applications have opened an array of opportunities for the digital therapeutics market. However, factors such as a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.
Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the digital therapeutics market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report: 
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market
• Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the digital therapeutics market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various digital therapeutics products across geographies 
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the digital therapeutics market

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 LIMITATIONS 20
1.6 MARKET STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 22
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.3 KEY DATA FROM SECONDARY SOURCES 26
2.4 KEY DATA FROM PRIMARY SOURCES 26
2.5 KEY INDUSTRY INSIGHTS 27
2.6 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 35
4.1 DIGITAL THERAPEUTICS MARKET OVERVIEW 35
4.2 DIGITAL THERAPEUTICS MARKET, BY APPLICATION 36
4.3 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS 36
4.4 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE APPLICATIONS 37
4.5 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 37
4.6 DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER 38
4.7 DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER 39
4.8 DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC SNAPSHOT 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Increasing incidence of preventable chronic diseases 43
5.2.1.2 Rising focus on preventive healthcare 43
5.2.1.3 Technological advancements 44
5.2.1.4 Need to control healthcare costs 44
5.2.1.5 Significant increase in venture capital investments 45
5.2.1.6 Benefits offered by digital therapeutics 45
5.2.1.6.1 Ability to induce behavioral change 45
5.2.1.6.2 Improved drug adherence 46
5.2.1.6.3 Patient convenience and user-friendliness 46
5.2.2 RESTRAINTS 47
5.2.2.1 Lack of awareness and access to digital therapeutics programs in developing countries 47
5.2.2.2 Patient data privacy concerns 47
5.2.2.3 Resistance from traditional healthcare providers 47
5.2.3 OPPORTUNITIES 48
5.2.3.1 Emerging markets offer significant growth opportunities 48
5.2.3.2 Large undiagnosed and untreated population 49
5.2.3.3 Unexplored therapeutic applications 49
5.2.4 CHALLENGES 50
5.2.4.1 Unfavorable payment models 50
5.2.4.2 Stringent regulatory guidelines 50
5.2.4.3 Reluctance among patients to adopt digital therapeutics 51

6 INDUSTRY INSIGHTS 52
6.1 INTRODUCTION 53
6.2 PORTER’S FIVE FORCES ANALYSIS 53
6.2.1 THREAT OF NEW ENTRANTS 54
6.2.2 BARGAINING POWER OF SUPPLIERS 54
6.2.3 BARGAINING POWER OF BUYERS 54
6.2.4 THREAT OF SUBSTITUTES 55
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.3 REGULATORY REQUIREMENTS 55
6.3.1 EMERGING REGULATORY FRAMEWORK FOR DIGITAL THERAPEUTICS 55
6.3.2 HEALTH INFORMATION PORTABILITY AND ACCOUNTABILITY ACT (HIPAA) 56
6.4 VENTURE CAPITAL INVESTMENTS 56
6.5 PIPELINE PRODUCTS 58

7 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL 60
7.1 INTRODUCTION 61
7.2 B2C 62
7.2.1 CAREGIVERS 65
7.2.2 PATIENTS 66
7.3 B2B 69
7.3.1 PROVIDERS 72
7.3.2 PAYERS 74
7.3.3 PHARMACEUTICAL COMPANIES 76
7.3.4 EMPLOYERS 77
7.3.5 OTHER BUYERS 79

8 DIGITAL THERAPEUTICS MARKET, BY TYPE OF APPLICATION 81
8.1 INTRODUCTION 82
8.2 PREVENTIVE APPLICATIONS 84
8.2.1 PREDIABETES 87
8.2.2 OBESITY 89
8.3 TREATMENT/CARE-RELATED APPLICATIONS 91
8.3.1 DIABETES 94
8.3.2 CENTRAL NERVOUS SYSTEM (CNS) DISORDERS 96
8.3.3 CHRONIC RESPIRATORY DISEASES (CRD) 98
8.3.4 MUSCULOSKELETAL DISORDERS 100
8.3.5 CARDIOVASCULAR DISEASES 102
8.3.6 SMOKING CESSATION 104
8.3.7 MEDICATION ADHERENCE 106
8.3.8 OTHER APPLICATIONS 108

9 DIGITAL THERAPEUTICS MARKET, BY REGION 110
9.1 INTRODUCTION 111
9.2 NORTH AMERICA 113
9.2.1 U.S. 118
9.2.2 CANADA 122
9.3 EUROPE 126
9.3.1 GERMANY 130
9.3.2 U.K. 133
9.3.3 FRANCE 136
9.3.4 SPAIN 139
9.3.5 REST OF EUROPE (ROE) 142
9.4 ASIA-PACIFIC (APAC) 145
9.5 REST OF THE WORLD (ROW) 149

10 COMPETITIVE LANDSCAPE 152
10.1 OVERVIEW 152
10.2 COMPETITIVE SITUATIONS AND TRENDS 155
10.2.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 156
10.2.2 INVESTMENTS 157
10.2.3 NEW PRODUCT LAUNCHES 158
10.2.4 OTHER STRATEGIES 159

11 COMPANY PROFILES 160
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION 160
11.2 PROTEUS DIGITAL HEALTH, INC. 161
11.3 OMADA HEALTH, INC. 163
11.4 WELLDOC, INC. 165
11.5 LIVONGO HEALTH 167
11.6 NOOM INC. 169
11.7 GINGER.IO, INC. 171
11.8 PROPELLER HEALTH 172
11.9 2MORROW INC. 173
11.10 CANARY HEALTH INC. 174
11.11 MANGO HEALTH INC. 175
11.12 CLICK THERAPEUTICS, INC.* 176
11.13 PEAR THERAPEUTICS, INC.* 177
11.14 AKILI INTERACTIVE LABS, INC.* 178
11.15 WELLTHY THERAPEUTICS PVT. LTD* 179
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12 APPENDIX 180
12.1 INSIGHTS FROM INDUSTRY EXPERTS 180
12.2 DISCUSSION GUIDE 181
12.3 OTHER DEVELOPMENTS, BY COMPANY, 2013–2016 184
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 187
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189
12.6 AVAILABLE CUSTOMIZATIONS 189
12.7 RELATED REPORTS 190
  


List Of Tables

TABLE 1 INCREASING INCIDENCE OF PREVENTABLE CHRONIC DISEASES: A MAJOR MARKET DRIVER 46
 TABLE 2 LACK OF AWARENESS AND ACCESS TO DIGITAL THERAPEUTICS PROGRAMS IN DEVELOPING COUNTRIES: A MAJOR RESTRAINT FOR MARKET GROWTH 48
 TABLE 3 EMERGING MARKETS OFFER SIGNIFICANT GROWTH OPPORTUNITIES 49
 TABLE 4 STRINGENT REGULATORY GUIDELINES: A MAJOR CHALLENGE FOR MARKET GROWTH 51
 TABLE 5 LIST OF VENTURE CAPITAL INVESTMENTS IN THE DIGITAL THERAPEUTICS MARKET (2007-2016) 56
 TABLE 6 LIST OF PIPELINE PRODUCTS IN THE MARKET (2015-2021) 58
 TABLE 7 DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 62
 TABLE 8 DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 63
 TABLE 9 DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY REGION, 2014-2021 (USD MILLION) 63
 TABLE 10 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION) 63
 TABLE 11 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 64
 TABLE 12 DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS, BY REGION,
 2014-2021 (USD MILLION) 65
 TABLE 13 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS,
 BY COUNTRY, 2014-2021 (USD MILLION) 65
 TABLE 14 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CAREGIVERS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 66
 TABLE 15 DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS, BY REGION,
 2014-2021 (USD THOUSAND) 67
 TABLE 16 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS,
 BY COUNTRY, 2014-2021 (USD MILLION) 67
 TABLE 17 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PATIENTS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 68
 TABLE 18 DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 70
 TABLE 19 DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY REGION, 2014-2021 (USD MILLION) 70
 TABLE 20 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY COUNTRY, 2014-2021 (USD MILLION) 71
 TABLE 21 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY COUNTRY, 2014-2021 (USD MILLION) 71
 TABLE 22 DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS, BY REGION,
 2014-2021 (USD MILLION) 72
 TABLE 23 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS,
 BY COUNTRY, 2014-2021 (USD MILLION) 73
 TABLE 24 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PROVIDERS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 73
 TABLE 25 DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY REGION,
 2014-2021 (USD MILLION) 74
 TABLE 26 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS,
 BY COUNTRY, 2014-2021 (USD MILLION) 75
 TABLE 27 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PAYERS, BY COUNTRY,
 2014-2021 (USD MILLION) 75
 TABLE 28 DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES,
 BY REGION, 2014-2021 (USD THOUSAND) 76
 TABLE 29 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION) 76
 TABLE 30 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2014-2021 (USD THOUSAND) 77
 TABLE 31 DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS, BY REGION,
 2014-2021 (USD MILLION) 78
 TABLE 32 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS,
 BY COUNTRY, 2014-2021 (USD MILLION) 78
 TABLE 33 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR EMPLOYERS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 79
 TABLE 34 DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS, BY REGION,
 2014-2021 (USD THOUSAND) 79
 TABLE 35 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 80
 TABLE 36 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER BUYERS,
 BY COUNTRY, 2014-2021 (USD THOUSAND) 80
 TABLE 37 DIGITAL THERAPEUTICS MARKET SIZE, BY TYPE OF APPLICATION,
 2014–2021 (USD MILLION) 83
 TABLE 39 DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 2014–2021 (USD MILLION) 85
 TABLE 40 DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY REGION, 2014–2021 (USD MILLION) 85
 TABLE 41 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 86
 TABLE 42 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 86
 TABLE 43 DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES, BY REGION,
 2014–2021 (USD MILLION) 87
 TABLE 44 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES,
 BY COUNTRY, 2014–2021 (USD MILLION) 88
 TABLE 45 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREDIABETES,
 BY COUNTRY, 2014–2021 (USD THOUSAND) 88
 TABLE 46 DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY, BY REGION,
 2014–2021 (USD MILLION) 89
 TABLE 47 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY,
 BY COUNTRY, 2014–2021 (USD MILLION) 90
 TABLE 48 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OBESITY,
 BY COUNTRY, 2014–2021 (USD MILLION) 90
 TABLE 49 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, 2014–2021 (USD MILLION) 92
 TABLE 50 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 92
 TABLE 51 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 93
 TABLE 52 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-RELATED APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 93
 TABLE 53 DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY REGION,
 2014–2021 (USD MILLION) 94
 TABLE 54 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES,
 BY COUNTRY, 2014–2021 (USD MILLION) 95
 TABLE 55 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR DIABETES, BY COUNTRY, 2014–2021 (USD MILLION) 95
 TABLE 56 DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS, BY REGION,
 2014–2021 (USD THOUSAND) 96
 TABLE 57 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS,
 BY COUNTRY, 2014–2021 (USD MILLION) 97
 TABLE 58 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CNS DISORDERS,
 BY COUNTRY, 2014–2021 (USD THOUSAND) 97
 TABLE 59 DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES,
 BY REGION, 2014–2021 (USD THOUSAND) 98
 TABLE 60 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 99
 TABLE 61 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2014–2021 (USD THOUSAND) 99
 TABLE 62 DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS,
 BY REGION, 2014–2021 (USD THOUSAND) 100
 TABLE 63 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014–2021 (USD MILLION) 101
 TABLE 64 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2014–2021 (USD THOUSAND) 101
 TABLE 65 DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES,
 BY REGION, 2014–2021 (USD MILLION) 102
 TABLE 66 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014–2021 (USD MILLION) 103
 TABLE 67 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2014–2021 (USD THOUSAND) 103
 TABLE 68 DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION,
 BY REGION, 2014–2021 (USD MILLION) 104
 TABLE 69 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION, BY COUNTRY, 2014–2021 (USD MILLION) 105
 TABLE 70 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR SMOKING CESSATION,
 BY COUNTRY, 2014–2021 (USD MILLION) 105
 TABLE 71 DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE,
 BY REGION, 2014–2021 (USD THOUSAND) 106
 TABLE 72 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE, BY COUNTRY, 2014–2021 (USD MILLION) 107
 TABLE 73 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR MEDICATION ADHERENCE,
 BY COUNTRY, 2014–2021 (USD THOUSAND) 107
 TABLE 74 DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS,
 BY REGION, 2014–2021 (USD THOUSAND) 108
 TABLE 75 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014–2021 (USD MILLION) 108
 TABLE 76 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR OTHER APPLICATIONS,
 BY COUNTRY, 2014–2021 (USD THOUSAND) 109
 TABLE 77 DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 112
 TABLE 78 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY,
 2014-2021 (USD MILLION) 115
 TABLE 79 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 115
 TABLE 80 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 115
 TABLE 81 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 116
 TABLE 82 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL, 2014-2021 (USD MILLION) 116
 TABLE 83 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION) 117
 TABLE 84 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL, BY BUYER, 2014-2021 (USD MILLION) 117
 TABLE 85 U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 119
 TABLE 86 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD MILLION) 119
 TABLE 87 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 120
 TABLE 88 U.S.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 120
 TABLE 89 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 121
 TABLE 90 U.S.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 121
 TABLE 91 CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 122
 TABLE 92 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 123
 TABLE 93 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 123
 TABLE 94 CANADA: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 124
 TABLE 95 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 124
 TABLE 96 CANADA: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 125
 TABLE 97 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY,
 2014-2021 (USD MILLION) 127
 TABLE 98 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 127
 TABLE 99 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 127
 TABLE 100 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 128
 TABLE 101 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 128
 TABLE 102 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 129
 TABLE 103 EUROPE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 129
 TABLE 104 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 130
 TABLE 105 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 130
 TABLE 106 DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD MILLION) 131
 TABLE 107 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 131
 TABLE 108 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 132
 TABLE 109 GERMANY: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 132
 TABLE 110 U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 133
 TABLE 111 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD MILLION) 133
 TABLE 112 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 134
 TABLE 113 U.K.: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 134
 TABLE 114 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 135
 TABLE 115 U.K.: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 135
 TABLE 116 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 136
 TABLE 117 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS, BY DISORDER, 2014–2021 (USD MILLION) 136
 TABLE 118 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 137
 TABLE 119 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 137
 TABLE 120 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 138
 TABLE 121 FRANCE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 138
 TABLE 122 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 139
 TABLE 123 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD THOUSAND) 139
 TABLE 124 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 140
 TABLE 125 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD THOUSAND) 140
 TABLE 126 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 141
 TABLE 127 SPAIN: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 141
 TABLE 128 ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 142
 TABLE 129 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD MILLION) 142
 TABLE 130 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 143
 TABLE 131 ROE: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD THOUSAND) 143
 TABLE 132 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 144
 TABLE 133 ROE: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 144
 TABLE 134 APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 146
 TABLE 135 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD MILLION) 146
 TABLE 136 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 147
 TABLE 137 APAC: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 147
 TABLE 138 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD MILLION) 148
 TABLE 139 APAC: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 148
 TABLE 140 ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION,
 2014–2021 (USD MILLION) 149
 TABLE 141 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR PREVENTIVE APPLICATIONS,
 BY DISORDER, 2014–2021 (USD MILLION) 149
 TABLE 142 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR TREATMENT/CARE-BASED APPLICATIONS, 2014–2021 (USD THOUSAND) 150
 TABLE 143 ROW: DIGITAL THERAPEUTICS MARKET SIZE, BY SALES CHANNEL,
 2014-2021 (USD MILLION) 150
 TABLE 144 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2C SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 151
 TABLE 145 ROW: DIGITAL THERAPEUTICS MARKET SIZE FOR B2B SALES CHANNEL,
 BY BUYER, 2014-2021 (USD THOUSAND) 151
 TABLE 146 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2016 156
 TABLE 147 INVESTMENTS, 2015–2016 157
 TABLE 148 NEW PRODUCT LAUNCHES, 2014–2016 158
 TABLE 149 OTHER STRATEGIES, 2013–2016 159
  


List Of Figures

FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 23
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 DIGITAL THERAPEUTICS FOR PREVENTIVE APPLICATIONS TO REGISTER HIGH GROWTH DURING THE FORECAST PERIOD 30
FIGURE 7 DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, 2016 VS. 2021 30
FIGURE 8 DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE APPLICATIONS,
2016 VS. 2021 31
FIGURE 9 DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL: B2B SALES CHANNEL EXPECTED TO DOMINATE THE MARKET IN 2016 32
FIGURE 10 CAREGIVERS SEGMENT TO REGISTER SIGNIFICANT GROWTH DURING THE FORECAST PERIOD 32
FIGURE 11 PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET DURING THE FORECAST PERIOD 33
FIGURE 12 DIGITAL THERAPEUTICS MARKET, BY REGION: NORTH AMERICA IS EXPECTED TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 34
FIGURE 13 VENTURE CAPITAL INVESTMENTS AND SUPPORTING GOVERNMENT INITIATIVES: MAJOR FACTORS DRIVING MARKET GROWTH 35
FIGURE 14 SOLUTIONS FOR TREATMENT/CARE SEGMENT TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016 36
FIGURE 15 OBESITY SEGMENT TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD 36
FIGURE 16 DIABETES TO DOMINATE THE MARKET BY 2021 37
FIGURE 17 B2B SEGMENT TO FORM THE LARGEST SALES CHANNEL IN 2016 37
FIGURE 18 CAREGIVERS TO BE THE LARGEST SEGMENT OF THE MARKET IN 2016 38
FIGURE 19 PAYERS TO COMMAND THE LARGEST MARKET SHARE IN 2016 39
FIGURE 20 U.S. TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD 40
FIGURE 21 DIGITAL THERAPEUTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 22 PORTER’S FIVE FORCES ANALYSIS 53
FIGURE 23 DIGITAL THERAPEUTICS MARKET SEGMENTATION, BY SALES CHANNEL 61
FIGURE 24 B2B SEGMENT TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, IN 2016 61
FIGURE 25 CAREGIVERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY B2C SALES CHANNEL, IN 2016 62
FIGURE 26 PAYERS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET, BY B2B SALES CHANNEL, IN 2016 69
FIGURE 27 DIGITAL THERAPEUTICS MARKET, BY TYPE OF APPLICATION 82
FIGURE 28 TREATMENT/CARE-RELATED APPLICATIONS TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016 83
FIGURE 29 OBESITY TO DOMINATE THE DIGITAL THERAPEUTICS APPLICATION MARKET
IN 2016 84
FIGURE 30 DIABETES TO DOMINATE THE DIGITAL THERAPEUTICS APPLICATION MARKET
IN 2016 91
FIGURE 31 NORTH AMERICA TO DOMINATE THE DIGITAL THERAPEUTICS MARKET IN 2016 111
FIGURE 32 NORTH AMERICA: DIGITAL THERAPEUTICS MARKET OVERVIEW 114
FIGURE 33 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2013 AND 2016 153
FIGURE 34 MARKET EVOLUTION FRAMEWORK 154
FIGURE 35 BATTLE FOR MARKET SHARE: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 155
FIGURE 36 PRODUCT PORTFOLIO MIX FOR THE TOP 5 PLAYERS 160

 


Europe Fluid Level Sensors Market Report 2016

Notes:Sales, means the sales volume of Fluid Level SensorsRevenue, means the sales value of Fluid Level SensorsThis report studies sales (consumption) of Fluid Level Sensors in Europe market, especially in

USD 3900View Report

Global Leveling Agents Market Research Report 2016

Notes:Production, means the output of Leveling AgentsRevenue, means the sales value of Leveling AgentsThis report studies Leveling Agents in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Europe Float Level Switch Market Report 2016

Notes:Sales, means the sales volume of Float Level SwitchRevenue, means the sales value of Float Level SwitchThis report studies sales (consumption) of Float Level Switch in Europe market, especially in

USD 3900View Report

United States Optical Transmitter Market Report 2016

Notes:Sales, means the sales volume of Optical TransmitterRevenue, means the sales value of Optical TransmitterThis report studies sales (consumption) of Optical Transmitter in United States market, focuses on the top

USD 3800View Report

Japan Radar Level Transmitter Market Report 2016

Notes:Sales, means the sales volume of Radar Level TransmitterRevenue, means the sales value of Radar Level TransmitterThis report studies sales (consumption) of Radar Level Transmitter in Japan market, focuses on

USD 3400View Report

United States Radar Level Transmitter Market Report 2016

Notes:Sales, means the sales volume of Radar Level TransmitterRevenue, means the sales value of Radar Level TransmitterThis report studies sales (consumption) of Radar Level Transmitter in United States market, focuses

USD 3800View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 5650
  • Multi User Licence    $ 6650
  • Corporate Licence    $ 8150
$ 5650

Reports Details

Published Date : Jan 2016
No. of Pages :155
Country :Global
Category :Semiconductors
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment